Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,589 | -20,308 | -8,892 | -3,290 | -13,060 |
| Depreciation Amortization | 2,095 | 253 | 162 | 54 | 440 |
| Accounts payable and accrued liabilities | -2,373 | 221 | 1,386 | 486 | 0 |
| Other Working Capital | -1,973 | -2,468 | 108 | -5 | -2,860 |
| Other Operating Activity | 3,946 | 176 | -1,284 | -389 | 760 |
| Operating Cash Flow | $-16,894 | $-22,126 | $-8,520 | $-3,144 | $-14,720 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -77 | -43 | -13 | -10 |
| Purchase Sale Intangibles | N/A | -315 | -214 | -92 | 0 |
| Other Investing Activity | 0 | -315 | -214 | -92 | -340 |
| Investing Cash Flow | $-1 | $-392 | $-257 | $-105 | $-350 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,980 | 4,500 | 4,500 | N/A | 0 |
| Debt Repayment | -2,000 | -4,500 | -4,500 | -630 | 0 |
| Common Stock Issued | 63 | 43,420 | 2 | 0 | 0 |
| Other Financing Activity | 0 | 7,790 | 8,510 | -50 | 20,600 |
| Financing Cash Flow | $10,043 | $51,210 | $8,512 | $-680 | $20,600 |
| Beginning Cash Position | 10,940 | 14,764 | 14,764 | 14,764 | 9,230 |
| End Cash Position | 4,088 | 43,456 | 14,499 | 10,835 | 14,760 |
| Net Cash Flow | $-6,852 | $28,692 | $-265 | $-3,929 | $5,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,894 | -22,126 | -8,520 | -3,144 | -14,720 |
| Capital Expenditure | -1 | -77 | -43 | -13 | 0 |
| Free Cash Flow | -16,895 | -22,203 | -8,563 | -3,157 | -14,720 |